2 unknown, 1 not yet recruiting, 1 recruiting. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Unknown 2, Not yet recruiting 1, Recruiting 1 |
Follow Small Cell Lung Cancer: new trials by email Literature Review of Small Cell Lung Cancer trials Research Report on Small Cell Lung Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction Liposome Irinotecan, Platinum, Tislelizumab - Small Cell Lung Cancer | Phase 4 | Not yet recruiting | China Medical University, China | 31 | 2025-04-30 | 2025-04-30 |
| Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer Irinotecan hydrochloride liposome injection - Small Cell Lung Cancer | Phase 4 | Recruiting | Tang-Du Hospital | 24 | 2024-03-15 | 2024-06-21 |
| Clinical Study of First-line Treatment of Small Cell Lung Cancer (SCLC) With Anlotinib Hydrochloride Anlotinib Hydrochloride - Small Cell Lung Cancer | Phase 4 | Unknown | Chifeng Municipal Hospital | 30 | 2019-04-01 | 2019-03-26 |
| Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer Irinotecan, Etoposide, Cisplatin - Small Cell Lung Cancer | Phase 4 | Unknown | Guangdong Association of Clinical Trials | 308 | 2015-02-01 | 2016-12-05 |
Bronchial Neoplasms (4) · Carcinoma, Bronchogenic (4) · Lung Diseases (4) · Lung Neoplasms (4) · Neoplasms (4) · Neoplasms by Site (4) · Respiratory Tract Diseases (4) · Respiratory Tract Neoplasms (4) · Thoracic Neoplasms (4)
Cisplatin (2) · Carboplatin (1) · Etoposide (1) · Immune Checkpoint Inhibitors (1) · Irinotecan (1) · Platinum (1) · anlotinib (1) · tislelizumab (1)
Chifeng Municipal Hospital (1) · China Medical University, China (1) · Guangdong Association of Clinical Trials (1) · Tang-Du Hospital (1)
China (3)
Haichuan Su, PhD (1) · Shun Lu, M.D (1) · Yunpeng Liu (1)